Burden of aspergillosis-related hospitalizations in the United States

被引：117

作者：

Dasbach, EJ ^{[1
]}

Davies, GM ^{[1
]}

Teutsch, SM ^{[1
]}

机构：

[1] Merck Res Labs, Blue Bell, PA 19422 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 06期

基金：

美国医疗保健研究与质量局;

关键词：

D O I：

10.1086/317487

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.

引用

页码：1524 / 1528

页数：5